Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.
about
"Stormy waters ahead": global emergence of carbapenemasesEmergence of Klebsiella pneumoniae carbapenemase-producing bacteriaOutbreak of colistin-resistant, carbapenem-resistant Klebsiella pneumoniae in metropolitan Detroit, MichiganThree decades of beta-lactamase inhibitorsCarbapenem resistance: overview of the problem and future perspectivesA structural, epidemiological & genetic overview of Klebsiella pneumoniae carbapenemases (KPCs)The role of epidemic resistance plasmids and international high-risk clones in the spread of multidrug-resistant Enterobacteriaceae.Tracking Nosocomial Klebsiella pneumoniae Infections and Outbreaks by Whole-Genome Analysis: Small-Scale Italian Scenario within a Single HospitalGenomic Analysis of the Emergence and Rapid Global Dissemination of the Clonal Group 258 Klebsiella pneumoniae PandemicRisk Factors and Outcomes for Carbapenem-Resistant Klebsiella pneumoniae Isolation, Stratified by Its Multilocus Sequence Typing: ST258 Versus Non-ST258.In vitro activity of fosfomycin against blaKPC-containing Klebsiella pneumoniae isolates, including those nonsusceptible to tigecycline and/or colistin.A Comparison of Molecular Typing Methods Applied to Enterobacter cloacae complex: hsp60 Sequencing, Rep-PCR, and MLSTInhibitor resistance in the KPC-2 beta-lactamase, a preeminent property of this class A beta-lactamase.OXA-48 carbapenemase-producing Salmonella enterica serovar Kentucky isolate of sequence type 198 in a patient transferred from Libya to Switzerland."Swimming in resistance": Co-colonization with carbapenem-resistant Enterobacteriaceae and Acinetobacter baumannii or Pseudomonas aeruginosa.The global challenge of carbapenem-resistant Enterobacteriaceae in transplant recipients and patients with hematologic malignanciesMolecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella pneumoniae Infections in Eastern ChinaOutcomes and genetic relatedness of carbapenem-resistant enterobacteriaceae at Detroit medical center.Surveillance of carbapenem-resistant Klebsiella pneumoniae: tracking molecular epidemiology and outcomes through a regional network.Infections caused by fluoroquinolone-resistant Escherichia coli following transrectal ultrasound-guided biopsy of the prostateAcinetobacter baumannii isolates from pets and horses in Switzerland: molecular characterization and clinical dataSubstrate selectivity and a novel role in inhibitor discrimination by residue 237 in the KPC-2 beta-lactamase.Evaluation of a commercial microarray system for detection of SHV-, TEM-, CTX-M-, and KPC-type beta-lactamase genes in Gram-negative isolates.Carbapenem-resistant Acinetobacter baumannii and Klebsiella pneumoniae across a hospital system: impact of post-acute care facilities on dissemination.Microbiological features of KPC-producing Enterobacter isolates identified in a U.S. hospital systemDrugs of last resort? The use of polymyxins and tigecycline at US Veterans Affairs medical centers, 2005-2010.Carbapenem-resistant Enterobacteriaceae: a menace to our most vulnerable patientsEmerging rapid resistance testing methods for clinical microbiology laboratories and their potential impact on patient management.Evaluation of updated interpretative criteria for categorizing Klebsiella pneumoniae with reduced carbapenem susceptibility.Evaluation of ceftazidime and NXL104 in two murine models of infection due to KPC-producing Klebsiella pneumoniaeTreatment and outcomes in carbapenem-resistant Klebsiella pneumoniae bloodstream infections.Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort.Comparison of polymyxin B, tigecycline, cefepime, and meropenem MICs for KPC-producing Klebsiella pneumoniae by broth microdilution, Vitek 2, and Etest.Complex prosthetic joint infections due to carbapenemase-producing Klebsiella pneumoniae: a unique challenge in the era of untreatable infections.Recent exposure to antimicrobials and carbapenem-resistant Enterobacteriaceae: the role of antimicrobial stewardship.Molecular characteristics of KPC-producing Enterobacteriaceae at the early stage of their dissemination in Poland, 2008-2009Worldwide diversity of Klebsiella pneumoniae that produce beta-lactamase blaKPC-2 gene.Genomic Epidemiology of an Endoscope-Associated Outbreak of Klebsiella pneumoniae Carbapenemase (KPC)-Producing K. pneumoniaeMultidrug-resistant (MDR) Klebsiella pneumoniae clinical isolates: a zone of high heterogeneity (HHZ) as a tool for epidemiological studies"Silent" dissemination of Klebsiella pneumoniae isolates bearing K. pneumoniae carbapenemase in a long-term care facility for children and young adults in Northeast Ohio.
P2860
Q21131125-D1D4DE33-B601-48CE-8F4A-B5B70AA59EEDQ24618178-553EF00D-47A6-4796-A307-69FE15FDBBCBQ24633186-A663A6F2-B85A-44B0-BD6B-9CB92A7C20ACQ24646623-B58FCC3A-B834-420F-B729-5ED7DF304C5EQ26767081-1B8DAABC-D2D6-42F3-9FC1-8AEC0EA7339FQ28078638-F1450236-3800-4551-95A1-F19A41898F39Q30300020-F1AC0A8B-F8CC-4110-ACA7-696E9B401C6DQ30376247-8EEB1F39-C74A-4A05-BEA3-FAA6DA8B0325Q30376996-993BB1A8-48A3-4A61-83FB-6DCBF4A2335DQ30384546-38F2BC9E-6A1D-4EA4-8228-B3C699AA282EQ33558996-7D22F169-CC29-4276-9636-772F3EBA46B7Q33573703-1E8B4C29-9765-4BAA-8D8E-D1189843D040Q33613797-8A85BB27-F13B-47A0-8F96-78211AC78A12Q33622846-AC6163EF-574B-467B-B59E-C76C88709668Q33648238-EB3BE562-C0C5-4B88-AFF2-7EF4FB691DEBQ33686940-19F61BDC-CFB6-44C9-8AB5-041C5B5B1EACQ33790342-5D3E73D7-0037-4D2F-9A3D-123E5ABC38ECQ33795389-045D6DD0-F592-4132-AB8F-A1D40BB577EBQ33798238-46E2D7D8-5681-44C8-87C0-88916AB1E68CQ33887625-2E1E8566-FDA3-4A74-B533-B7DD7CEF83F2Q33953265-3719ED85-3EDF-43CB-9ECF-567BBBB7BBD2Q33962811-F8959109-F565-4DDE-94F1-8AD79B59EF1CQ33963663-774569EC-BA01-4FEA-8B50-A64A1471F261Q33997664-362F2CDA-ACB7-4F58-9F1C-ED6D81E24E78Q34183819-C50CFB61-F144-4490-964F-270054BF436BQ34277350-14B69C9E-5B39-49D2-B292-04213576BF57Q34336456-ED5F01C0-A593-4319-A469-2BBB63C73E3DQ34342514-8DB2A55B-E8F9-426A-8E65-768344F672BFQ34433108-0AE7AF2D-5EEF-4DE4-BA90-40A706324487Q34483491-C9D2735C-1E09-45FC-9D6F-1D1739C79568Q34678004-28A6DCF5-E2C8-4F25-92AF-FA2B147BE9A4Q34906223-D40E9F25-482A-47C1-AEBD-CEA4403D265BQ35066622-A714029F-051F-4D00-A41A-F1EF5C32857BQ35106776-086CAF27-2686-461B-92E4-B86BB3C83FCCQ35207767-30499B98-A05D-4C4D-8048-A287B1BA868FQ35598362-4F4225F9-4E84-44F0-8E2E-CF045A32B464Q35806497-EE218E7A-D2B0-45CA-B09A-C3786C323685Q35861216-1C887990-7E1B-408F-AD0B-389D5542DF08Q36040776-03D4FDE0-944A-4DC3-83FE-CF4A323314FFQ36115511-309561A1-0ECD-4685-9C5C-3DF6BB7E22AC
P2860
Characterization of blaKPC-containing Klebsiella pneumoniae isolates detected in different institutions in the Eastern USA.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 20 January 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Characterization of blaKPC-con ...... stitutions in the Eastern USA.
@en
Characterization of blaKPC-con ...... stitutions in the Eastern USA.
@nl
type
label
Characterization of blaKPC-con ...... stitutions in the Eastern USA.
@en
Characterization of blaKPC-con ...... stitutions in the Eastern USA.
@nl
prefLabel
Characterization of blaKPC-con ...... stitutions in the Eastern USA.
@en
Characterization of blaKPC-con ...... stitutions in the Eastern USA.
@nl
P2093
P2860
P356
P1476
Characterization of blaKPC-con ...... stitutions in the Eastern USA.
@en
P2093
Andrea Endimiani
Christopher R Bethel
Daniel J Diekema
David L Paterson
Federico Perez
Fred C Tenover
Gerri S Hall
Jennifer Kroeger
Kristine M Hujer
Louis B Rice
P2860
P304
P356
10.2217/THY.09.3
P407
P577
2009-01-20T00:00:00Z